GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Endoscopy/Endoscopy and Gastric Varices(Endoscopy, Jan-2026)

Endoscopy and Gastric Varices(Endoscopy, Jan-2026)

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated January 1, 2026

Quick Answer

**Role of Endoscopy in Gastric Varices:** Endoscopy is a critical tool in the diagnosis and management of gastric varices in patients with cirrhosis. Gastric varices are enlarged veins in the stomach that develop due to increased portal venous pressure, often associated with liver cirrhosis.


**Role of Endoscopy in Gastric Varices:**

Endoscopy is a critical tool in the diagnosis and management of gastric varices in patients with cirrhosis. Gastric varices are enlarged veins in the stomach that develop due to increased portal venous pressure, often associated with liver cirrhosis. When these varices bleed, they can lead to life-threatening hemorrhage, making endoscopic intervention essential.

**Study Insights:**

1. **Treatment Approaches:** In the study, two endoscopic strategies were compared:

  • **Aggressive Endotherapy:** Obliteration of all visible gastric varices using cyanoacrylate glue, regardless of bleeding status or risk features.
  • **Conservative Endotherapy:** Treatment limited to varices with stigmata of recent hemorrhage or high-risk features.

2. **Outcomes:**

  • **Rebleeding Rates:** At one year, rebleeding rates were similar between the aggressive and conservative groups (18.2% vs. 15.0%).
  • **Mortality:** All-cause mortality was also comparable, with a nonsignificant trend toward lower mortality in the aggressive group.
  • **Efficiency:** Aggressive therapy achieved faster obliteration of varices and required fewer endoscopic sessions for GOV1 varices.

3. **Adverse Events:** The rates of complications were similar between the two groups, indicating that aggressive therapy did not increase the risk of adverse events.

**Conclusion:**

Endoscopy, specifically through the use of cyanoacrylate glue injection, is a highly effective method for managing gastric varices. The study suggests that while aggressive therapy may lead to faster variceal obliteration, it does not significantly improve rebleeding or mortality outcomes compared to a conservative approach. This highlights the importance of tailoring endoscopic treatment strategies to individual patient risk factors and clinical scenarios.

Related Q&A

EndoBarrier Improves Diabetes and Weight Loss: Ann Surg | July 2026

Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...

Immediate Endoscopic Necrosectomy in Necrotizing Pancreatitis: Gastroenterology | July 2026

Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...

Endoscopy After Bevacizumab Appears Safe: GIE | July 2026

Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...

Colorectal ESD Perforation: Endoscopy | July 2026

Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...

Duodenal Mucosal Resurfacing REMAIN-1 Study: DDW | 2026

Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...

EUS-FNAB for Solid Pancreatic Lesions: GIE | July 2026

Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer